TY - JOUR
KW - addiction recovery
KW - Opioids
KW - treatment retention
AU - A. C. Lynch
AU - A. N. Weber
AU - S. Hedden
AU - S. Sabbagh
AU - S. Arndt
AU - L. Acion
A1 - 
AB - BACKGROUND: Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD. OBJECTIVES: To assess 3-month outcomes pilot data from a patient-centered OUD treatment program in Iowa, USA, that utilized flexible treatment requirements and prioritized engagement over compliance. METHODS: Forty patients (62.5% female: mean age was 35.7 years, SD 9.5) receiving medication, either buprenorphine or naltrexone, to treat OUD were enrolled in an observational study. Patients could select or decline case management, counseling, and peer recovery groups. Substance use, risk and protective factors, and recovery capital were measured at intake and 3 months. RESULTS: Most participants reported increased recovery capital. The median Assessment of Recovery Capital (ARC) score went from 37 at enrollment to 43 (p < 0.01). Illegal drug use decreased, with the median days using illegal drugs in the past month dropping from 10 to 0 (p < 0.001). Cravings improved: 29.2% reported no cravings at intake and 58.3% reported no cravings at 3 months (p < 0.001). Retention rate was 92.5% at 3 months. Retention rate for participants who were not on probation/parole was higher (96.9%) than for those on probation/parole (62.5%, p = 0.021). CONCLUSION: This study shows preliminary evidence that a care model based on easy and flexible access and strategies to improve treatment retention improves recovery capital, reduces illegal drug use and cravings, and retains people in treatment.
AD - Department of Psychiatry, University of Iowa, Iowa City, IA, USA. alison-lynch@uiowa.edu.; Department of Family Medicine, University of Iowa, Iowa City, IA, USA. alison-lynch@uiowa.edu.; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.; Instituto de Cálculo, Universidad de Buenos Aires - CONICET, Buenos Aires, Argentina.
BT - Substance abuse treatment, prevention, and policy
C5 - Opioids & Substance Use
CP - 1
DO - 10.1186/s13011-021-00342-5
IS - 1
JF - Substance abuse treatment, prevention, and policy
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD. OBJECTIVES: To assess 3-month outcomes pilot data from a patient-centered OUD treatment program in Iowa, USA, that utilized flexible treatment requirements and prioritized engagement over compliance. METHODS: Forty patients (62.5% female: mean age was 35.7 years, SD 9.5) receiving medication, either buprenorphine or naltrexone, to treat OUD were enrolled in an observational study. Patients could select or decline case management, counseling, and peer recovery groups. Substance use, risk and protective factors, and recovery capital were measured at intake and 3 months. RESULTS: Most participants reported increased recovery capital. The median Assessment of Recovery Capital (ARC) score went from 37 at enrollment to 43 (p < 0.01). Illegal drug use decreased, with the median days using illegal drugs in the past month dropping from 10 to 0 (p < 0.001). Cravings improved: 29.2% reported no cravings at intake and 58.3% reported no cravings at 3 months (p < 0.001). Retention rate was 92.5% at 3 months. Retention rate for participants who were not on probation/parole was higher (96.9%) than for those on probation/parole (62.5%, p = 0.021). CONCLUSION: This study shows preliminary evidence that a care model based on easy and flexible access and strategies to improve treatment retention improves recovery capital, reduces illegal drug use and cravings, and retains people in treatment.
PY - 2021
SN - 1747-597X; 1747-597X
SP - 021
EP - 5
EP - 8+
T1 - Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA
T2 - Substance abuse treatment, prevention, and policy
TI - Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA
U1 - Opioids & Substance Use
U2 - 33435993
U3 - 10.1186/s13011-021-00342-5
VL - 16
VO - 1747-597X; 1747-597X
Y1 - 2021
Y2 - Jan 12
ER -